License and distribution system of OTCs to be drastically ameliorated

Published: 2003-02-12 07:00:00

Updated: 2003-02-12 07:00:00

During a brief session with the Korea Food and Drug Administration (KFDA) on February 6, ten leading OTC markers including Dongwha Pharma and Yuhan Corp. urged the government to ameliorate the OTC-related regulations concerning license, distribution and advertisement for further activation of OTC...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK